Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

140
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
140
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

178
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
178
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

324
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
324
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

226
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
226
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

241
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
241
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

204
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
204

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Navigating the dual burden of diabetes mellitus and tuberculosis: A comprehensive review of clinical and public health strategies.

The Indian journal of tuberculosis·2025
Same author

Prevalence and impact of anxiety and depression in patients with chronic obstructive pulmonary disease: a comparative analysis of post-tuberculosis and non-tuberculosis chronic obstructive pulmonary disease cases.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2025
Same author

Clinical profile, risk factors, disease severity, and outcome for COVID-19 disease in patients with tuberculosis on treatment under the National Tuberculosis Elimination Program: a cohort of 1400 patients.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2024
Same author

Is it the time for abandoning longer regimens for drug-resistant tuberculosis.

The Indian journal of tuberculosis·2024
Same author

Study of risk factors and clinical management of patients with clinical non-response due to low plasma levels of anti-tubercular drugs.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2024
Same author

Chronic pulmonary aspergillosis in a tertiary tuberculosis institute: A common entity missed commonly.

The Indian journal of tuberculosis·2023

Related Experiment Video

Updated: Jun 27, 2025

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

5.7K

Latent tuberculosis diagnostics: current scenario and review.

Amitesh Gupta1, Eshutosh Chandra1, Shipra Anand1

  • 1Department of Pulmonary Medicine, Maulana Azad Medical College and associated Lok Nayak Hospital, New Delhi.

Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|May 3, 2024
PubMed
Summary

Diagnosing latent tuberculosis infection (LTBI) requires improved methods to prevent active disease progression. This review examines current LTBI diagnostics, challenges, and treatment strategies to meet global tuberculosis (TB) reduction goals.

More Related Videos

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.8K

Related Experiment Videos

Last Updated: Jun 27, 2025

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

5.7K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.8K

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Latent tuberculosis infection (LTBI) is a critical reservoir for active tuberculosis (TB).
  • Addressing LTBI is essential for achieving World Health Organization (WHO) targets to reduce TB incidence and mortality.
  • High TB prevalence regions, like India, face significant challenges in managing LTBI.

Purpose of the Study:

  • To comprehensively review contemporary diagnostics for latent tuberculosis infection (LTBI).
  • To emphasize the global impact and complexities of LTBI diagnosis and treatment.
  • To highlight the need for improved diagnostic, preventive, and treatment strategies for TB.

Main Methods:

  • Review of current literature on LTBI diagnostics, including tuberculin skin testing (TST) and interferon-γ release assays (IGRAs).
  • Analysis of risk factors for LTBI progression to active TB.
  • Examination of challenges and limitations in LTBI diagnostic assays.

Main Results:

  • Current LTBI diagnostic assays, TST and IGRAs, have distinct advantages and limitations.
  • Interpretation of TST and IGRA results varies across different populations and settings.
  • Factors like compromised immunity, HIV co-infection, and immunosuppressive states increase the risk of LTBI progression.

Conclusions:

  • There is an urgent need to overcome challenges in LTBI diagnosis.
  • Further research into the heritability of immune responses and the role of antibodies may offer new diagnostic avenues.
  • Improved LTBI management is crucial for global TB control efforts.